Skip to content
University of Colorado Anschutz Medical Campus CU Anschutz
  • Webmail
  • UCD Access
  • Canvas
  • Quick Links
 

Tools & Resources

  • Events Calendar
  • Newsroom
  • Strauss Health Sciences Library
  • Department A-Z Directory
  • Campus Directory
  • Leadership
  • Faculty & Staff Resources
  • Supporter & Alumni Resources
  • Student Resources
  • Campus Map
  • University Policies
  • Give Now

CU Campuses

  • CU Anschutz Medical Campus
  • CU Boulder
  • CU Colorado Springs
  • CU Denver
  • CU System
  • CU Online

CU Anschutz Medical Campus

  • School of Dental Medicine
  • Graduate School
  • School of Medicine
  • College of Nursing
  • Skaggs School of Pharmacy and Pharmaceutical Sciences
  • Colorado School of Public Health

CU Research Imaging Center

School of Medicine

  • Home
  • Our Team
  • PET/CT
  • PET/MR
  • Radiochemistry
  • Quantitative Image Analysis
  • Research Rates
  • Parking
  • Contact Us
University Quick Links
pet-mr-scannerd
PET/MR

The CU-RIC operates a state-of-the-art GE Signa PET/MR scanner that combines a clinical-grade 3-Tesla MR scanner with a series of PET detector rings centered within the MR magnet that allow simultaneous acquisition of data for MR and PET modalities. While MR can yield both excellent anatomical detail and brain activity localization, it cannot yield specific biomolecular/biochemical information. PET radiopharmaceutical agents can be designed to target/bind with specific molecular tissue or interact in a specific biochemical reaction. PET radiopharmaceuticals can be used for diagnosis, interrogation of molecular pathways, targeted therapy, and monitoring response to therapy. The combination of PET with MR allows simultaneous, precise co-registration of both anatomical and physiological information from any part of the body.

For imaging of traumatic brain injury (TBI), PET/MR yields high resolution anatomical information about associated structural changes, while PET allows the detection/ investigation of the development of early neuro-inflammation, microglial activation, and accumulation of tau proteins by use of PET agents that can specifically target these processes. PET/MR may be able to allow earlier diagnosis, track progression, and evaluate response to therapy.

Other disease processes that would benefit from similar capabilities of PET/MR include Alzheimer’s, multiple sclerosis, movement disorders, personalized medicine, cancer, cardiac disease, and metabolic disorders. 

  • Contact Us
  • Website Feedback
  • CU System
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Accreditation
  • Employment
  • Give Now
 

© 2022 The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.

CMS Login

Webmail

UCD Access

Canvas

Opens in a new window Opens document in a new window